Terms: = Leukemia AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Treatment
43 results:
1. Determination of drug-related problems in the hematology service: a prospective interventional study.
Albayrak A; Özbalcı D
BMC Cancer; 2024 May; 24(1):552. PubMed ID: 38698336
[TBL] [Abstract] [Full Text] [Related]
2. Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases.
Fukuta T; Tanaka T; Hashimoto T; Isahaya K; Kubo Y; Yamano Y; Satomi K; Hiraoka N; Shirakawa N; Arakawa A; Ogawa C; Nishimura N; Aoki J; Ito A; Inamoto Y; Kim SW; Fukuda T
Int J Hematol; 2023 Jun; 117(6):933-940. PubMed ID: 36705847
[TBL] [Abstract] [Full Text] [Related]
3. Pharmacogenomic Profiling of Pediatric Acute Myeloid leukemia to Identify Therapeutic Vulnerabilities and Inform Functional Precision Medicine.
Wang H; Chan KYY; Cheng CK; Ng MHL; Lee PY; Cheng FWT; Lam GKS; Chow TW; Ha SY; Chiang AKS; Leung WH; Leung AYH; Wang CC; Zhang T; Zhang XB; So CC; Yuen YP; Sun Q; Zhang C; Xu Y; Cheung JTK; Ng WH; Tang PM; Kang W; To KF; Lee WYW; Wong RSM; Poon ENY; Zhao Q; Huang J; Chen C; Yuen PMP; Li CK; Leung AWK; Leung KT
Blood Cancer Discov; 2022 Nov; 3(6):516-535. PubMed ID: 35960210
[TBL] [Abstract] [Full Text] [Related]
4. Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis.
Bröckelmann PJ; Müller H; Gillessen S; Yang X; Koeppel L; Pilz V; Marinello P; Kaskel P; Raut M; Fuchs M; Borchmann P; Engert A; von Tresckow B
Leukemia; 2022 Mar; 36(3):772-780. PubMed ID: 34628472
[TBL] [Abstract] [Full Text] [Related]
5. The effect of hospital care volume on overall survival of children with cancer in Southern Brazil.
Arancibia AM; De Farias CB; Brunetto AL; Roesler R; Gregianin LJ
Pediatr Blood Cancer; 2021 Mar; 68(3):e28779. PubMed ID: 33118699
[TBL] [Abstract] [Full Text] [Related]
6. treatment outcomes in children with Acute lymphoblastic leukemia with versus without coexisting Down's syndrome: A systematic review and meta-analysis.
Liao W; Liu Y
Medicine (Baltimore); 2020 Jul; 99(29):e21015. PubMed ID: 32702842
[TBL] [Abstract] [Full Text] [Related]
7. Estimation of Total Costs in Pediatric and Young Adult Patients with Relapsed or Refractory Acute Lymphoblastic leukemia Receiving Tisagenlecleucel from a U.S. Hospital's Perspective.
Yang H; Hao Y; Qi CZ; Chai X; Wu EQ
J Manag Care Spec Pharm; 2020 Aug; 26(8):971-980. PubMed ID: 32525730
[TBL] [Abstract] [Full Text] [Related]
8. Sweet syndrome associated with malignancies: A retrospective analysis of 25 patients from West China hospital.
Dan H; Yanmei L; Yue X; Xian J
Dermatol Ther; 2020 Jul; 33(4):e13588. PubMed ID: 32410345
[TBL] [Abstract] [Full Text] [Related]
9. The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.
Conley BA; Staudt L; Takebe N; Wheeler DA; Wang L; Cardenas MF; Korchina V; Zenklusen JC; McShane LM; Tricoli JV; Williams PM; Lubensky I; O'Sullivan-Coyne G; Kohn E; Little RF; White J; Malik S; Harris LN; Mann B; Weil C; Tarnuzzer R; Karlovich C; Rodgers B; Shankar L; Jacobs PM; Nolan T; Berryman SM; Gastier-Foster J; Bowen J; Leraas K; Shen H; Laird PW; Esteller M; Miller V; Johnson A; Edmondson EF; Giordano TJ; Kim B; Ivy SP
J Natl Cancer Inst; 2021 Jan; 113(1):27-37. PubMed ID: 32339229
[TBL] [Abstract] [Full Text] [Related]
10. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Beelen DW; Trenschel R; Stelljes M; Groth C; Masszi T; Reményi P; Wagner-Drouet EM; Hauptrock B; Dreger P; Luft T; Bethge W; Vogel W; Ciceri F; Peccatori J; Stölzel F; Schetelig J; Junghanß C; Grosse-Thie C; Michallet M; Labussiere-Wallet H; Schaefer-Eckart K; Dressler S; Grigoleit GU; Mielke S; Scheid C; Holtick U; Patriarca F; Medeot M; Rambaldi A; Micò MC; Niederwieser D; Franke GN; Hilgendorf I; Winkelmann NR; Russo D; Socié G; Peffault de Latour R; Holler E; Wolff D; Glass B; Casper J; Wulf G; Menzel H; Basara N; Bieniaszewska M; Stuhler G; Verbeek M; Grass S; Iori AP; Finke J; Benedetti F; Pichlmeier U; Hemmelmann C; Tribanek M; Klein A; Mylius HA; Baumgart J; Dzierzak-Mietla M; Markiewicz M
Lancet Haematol; 2020 Jan; 7(1):e28-e39. PubMed ID: 31606445
[TBL] [Abstract] [Full Text] [Related]
11. Economic and Clinical Burden of Relapsed and/or Refractory Active treatment Episodes in Patients with Acute Myeloid leukemia (AML) in the USA: A Retrospective Analysis of a Commercial Payer Database.
Pandya BJ; Chen CC; Medeiros BC; McGuiness CB; Wilson S; Horvath Walsh LE; Wade RL
Adv Ther; 2019 Aug; 36(8):1922-1935. PubMed ID: 31222713
[TBL] [Abstract] [Full Text] [Related]
12. Minimal Residual Disease-guided Risk Restratification and Therapy Improves the Survival of Childhood Acute Lymphoblastic leukemia: Experience From a Tertiary Children's Hospital in China.
Liao C; Xu X; Shen D; Song H; Xu W; Zhao F; Yang S; Shi S; Liang J; Li S; Tang Y
J Pediatr Hematol Oncol; 2019 Aug; 41(6):e346-e354. PubMed ID: 30640823
[TBL] [Abstract] [Full Text] [Related]
13. [Global and disease-free survival in a peruvian cohort of patients with acute lymphoblastic leukemia].
Castro-Arechaga S; Ronceros-Salas L; Vega-Centeno S; Moreno M; Soto A
Rev Peru Med Exp Salud Publica; 2018; 35(3):416-425. PubMed ID: 30517501
[TBL] [Abstract] [Full Text] [Related]
14. Prevalence, predictors, causes of treatment refusal and abandonment in children with acute lymphoblastic leukaemia over 18 years in North India. treatment phase affecting factors: A step towards better focussed counselling.
Alam A; Kumar A
Cancer Epidemiol; 2018 Dec; 57():53-59. PubMed ID: 30316108
[TBL] [Abstract] [Full Text] [Related]
15. [A long-term follow-up study of 82 children with acute myeloid leukemia].
Ruan M; Qi BQ; Liu F; Liu TF; Liu XM; Chen XJ; Yang WY; Guo Y; Zhang L; Zou Y; Chen YM; Zhu XF
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):730-734. PubMed ID: 30293275
[No Abstract] [Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases.
Tomizawa D; Yoshida M; Kondo T; Miyamura T; Taga T; Adachi S; Koh K; Noguchi M; Kakuda H; Watanabe K; Cho Y; Fukuda T; Kato M; Shiba N; Goto H; Okada K; Inoue M; Hashii Y; Atsuta Y; Ishida H
Bone Marrow Transplant; 2019 Mar; 54(3):393-401. PubMed ID: 29959436
[TBL] [Abstract] [Full Text] [Related]
17. Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis.
Cargnin S; Ravegnini G; Soverini S; Angelini S; Terrazzino S
Pharmacol Res; 2018 May; 131():244-254. PubMed ID: 29427770
[TBL] [Abstract] [Full Text] [Related]
18. Intravoxel incoherent motion diffusion-weighted imaging of bone marrow in patients with acute myeloid leukemia: a pilot study of prognostic value.
Niu J; Li W; Wang H; Wu W; Gong T; Huang N; Wang J; Qi Y
J Magn Reson Imaging; 2017 Aug; 46(2):476-482. PubMed ID: 28211619
[TBL] [Abstract] [Full Text] [Related]
19. Is a biomarker-based diagnostic strategy for invasive aspergillosis cost effective in high-risk haematology patients?
Macesic N; Morrissey CO; Liew D; Bohensky MA; Chen SC; Gilroy NM; Milliken ST; Szer J; Slavin MA
Med Mycol; 2017 Oct; 55(7):705-712. PubMed ID: 28131991
[TBL] [Abstract] [Full Text] [Related]
20. Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014.
Mokdad AH; Dwyer-Lindgren L; Fitzmaurice C; Stubbs RW; Bertozzi-Villa A; Morozoff C; Charara R; Allen C; Naghavi M; Murray CJ
JAMA; 2017 Jan; 317(4):388-406. PubMed ID: 28118455
[TBL] [Abstract] [Full Text] [Related]
[Next]
